Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-003818
Filing Date
2020-02-10
Accepted
2020-02-10 16:20:28
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3211
  Complete submission text file 0000899243-20-003818.txt   4823
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 324 S. HYDE PARK AVENUE STE 350 TAMPA FL 33606
Business Address
Watson W. Mark (Reporting) CIK: 0001612372 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-13467 | Film No.: 20592216